Aarhus University Seal

Publications

Sort by: Date | Author | Title

Yang, M. N., Huang, R., Liu, X., Xu, Y. J., Wang, W. J., He, H., Zhang, G. H., Zheng, T., Fang, F., Fan, J. G., Li, F., Zhang, J., Li, J., Ouyang, F., Luo, Z. C. & the Shanghai Birth Cohort (2022). Fibroblast Growth Factor 19 in Gestational Diabetes Mellitus and Fetal Growth. Frontiers in Endocrinology, 12, Article 805722. https://doi.org/10.3389/fendo.2021.805722
Reyes, C., León-Muñoz, L. M., Pistillo, A., Jóhannesdóttir Schmidt, S. A., Kristensen, K. B., Puente, D., LLorente-García, A., Huerta-Álvarez, C., Pottegård, A. & Duarte-Salles, T. (2022). Flecainide and risk of skin neoplasms: Results of a large nested case–control study in Spain and Denmark. Frontiers in Pharmacology, 13, Article 1002451. https://doi.org/10.3389/fphar.2022.1002451
Thurin, N. H., Pajouheshnia, R., Roberto, G., Dodd, C., Hyeraci, G., Bartolini, C., Paoletti, O., Nordeng, H., Wallach-Kildemoes, H., Ehrenstein, V., Dudukina, E., MacDonald, T., De Paoli, G., Loane, M., Damase-Michel, C., Beau, A. B., Droz-Perroteau, C., Lassalle, R., Bergman, J. ... Gini, R. (2022). From Inception to ConcePTION: Genesis of a Network to Support Better Monitoring and Communication of Medication Safety During Pregnancy and Breastfeeding. Clinical Pharmacology and Therapeutics, 111(1), 321-331. https://doi.org/10.1002/cpt.2476
Yang, M. N., Huang, R., Zheng, T., Dong, Y., Wang, W. J., Xu, Y. J., Mehra, V., Zhou, G. D., Liu, X., He, H., Fang, F., Li, F., Fan, J. G., Zhang, J., Ouyang, F., Briollais, L., Li, J., Luo, Z. C. & for the Shanghai Birth Cohort (2022). Genome-wide placental DNA methylations in fetal overgrowth and associations with leptin, adiponectin and fetal growth factors. Clinical Epigenetics, 14, Article 192. https://doi.org/10.1186/s13148-022-01412-6
Willis, S. K., Wise, L. A., Laursen, A. S. D., Wesselink, A. K., Mikkelsen, E. M., Tucker, K. L., Rothman, K. J. & Hatch, E. E. (2022). Glycemic Load, Dietary Fiber, Added Sugar and Spontaneous Abortion in Two Preconception Cohorts. The Journal of Nutrition, 152(12), 2818-2826. https://doi.org/10.1093/jn/nxac202
Lykke, M. R. (2022). Group-B-streptococcal disease in the neonatal period and risk of epilepsy. Abstract from Group B Strep in Pregnancy & Babies Virtual Conference.
Lykke, M. R. (2022). Group-B-streptococcal disease in the neonatal period and risk of epilepsy. Poster session presented at 5th Annual Research Meeting at the Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark.
Lykke, M. R. (2022). Group-B-streptococcal disease in the neonatal period and risk of epilepsy. Abstract from Inflammatory network day , Aarhus .
Gonçalves, B. P., Procter, S. R., Paul, P., Chandna, J., Lewin, A., Seedat, F., Koukounari, A., Dangor, Z., Leahy, S., Santhanam, S., John, H. B., Bramugy, J., Bardají, A., Abubakar, A., Nasambu, C., Libster, R., Sánchez Yanotti, C., Horváth-Puhó, E., Sørensen, H. T. ... CHAMPS team (2022). Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden. The Lancet Global Health, 10(6), e807-e819. https://doi.org/10.1016/S2214-109X(22)00093-6
Dixon, P. H., Levine, A. P., Cebola, I., Chan, M. M. Y., Amin, A. S., Aich, A., Mozere, M., Maude, H., Mitchell, A. L., Zhang, J., NIHR BioResource, Genomics England Research Consortium Collaborators, Chambers, J., Syngelaki, A., Donnelly, J., Cooley, S., Geary, M., Nicolaides, K. H., Thorsel, M. ... Williamson, C. (2022). GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements. Nature Communications, 13(1), Article 4840. https://doi.org/10.1038/s41467-022-29931-z
Christensen, S. F., Svingel, L. S., Kjærsgaard, A., Stenling, A., Darvalics, B., Paulsson, B., Andersen, C. L., Christiansen, C. F., Stentoft, J., Starklint, J., Severinsen, M. T., Clausen, M. B., Hilsøe, M. H., Hasselbalch, H. C., Frederiksen, H., Mikkelsen, E. M. & Bak, M. (2022). Healthcare resource utilization in patients with myeloproliferative neoplasms: A Danish nationwide matched cohort study. European Journal of Haematology, 109(5), 526-541. https://doi.org/10.1111/ejh.13841
Gehrt, L., Laake, I., Englund, H., Nieminen, H., Benn, C. S., Feiring, B., Trogstad, L., Palmu, A. A. & Sørup, S. (2022). Hospital Contacts for Infectious Diseases Among Children in Denmark, Finland, Norway, and Sweden, 2008-2017. Clinical epidemiology, 14, 609-621. https://doi.org/10.2147/CLEP.S355193
Horsbøl, T. A., Dalton, S. O., Christensen, J., Petersen, A. C., Azawi, N., Donskov, F., Holm, M. L., Nørgaard, M. & Lund, L. (2022). Impact of comorbidity on renal cell carcinoma prognosis: a nationwide cohort study. Acta Oncologica, 61(1), 58-63. https://doi.org/10.1080/0284186X.2021.2005255
Hansen, K. N., Maeng, M., Raungaard, B., Engstrøm, T., Veien, K. T., Kristensen, S. D., Ellert-Gregersen, J., Jensen, S. E., Junker, A., Kahlert, J., Jakobsen, L., Christiansen, E. H. & Jensen, L. O. (2022). Impact of diabetes on 1-year clinical outcome in patients undergoing revascularization with the BioFreedom stents or the Orsiro stents from the SORT OUT IX trial. Catheterization and Cardiovascular Interventions, 99(4), 1095-1103. https://doi.org/10.1002/ccd.30090
Hansen, K. N., Noori, M., Christiansen, E. H., Kristiansen, E. B., Maeng, M., Zwisler, A. D. O., Borregaard, B., Søgaard, R., Veien, K. T., Junker, A. & Jensen, L. O. (2022). Impact of diabetes on long-term all-cause re-hospitalization after revascularization with percutaneous coronary intervention. Diabetes & vascular disease research, 19(4). https://doi.org/10.1177/14791641221113788
Lefort, M., Sharmin, S., Andersen, J. B., Vukusic, S., Casey, R., Debouverie, M., Edan, G., Ciron, J., Ruet, A., De Sèze, J., Maillart, E., Zephir, H., Labauge, P., Defer, G., Lebrun-Frenay, C., Moreau, T., Berger, E., Clavelou, P., Pelletier, J. ... Leray, E. (2022). Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis. BMC Medical Research Methodology, 22(1), Article 155. https://doi.org/10.1186/s12874-022-01623-8
Irmola, T., Ponkilainen, V., Mäkelä, K. T., Robertsson, O., W-Dahl, A., Furnes, O., Fenstad, A. M., Pedersen, A. B., Schrøder, H. M., Niemeläinen, M. J. & Eskelinen, A. (2022). Impact of the Nordic Arthroplasty Register Association (NARA) collaboration on demographics, methods and revision rates in knee arthroplasty: a register-based study from NARA 2000–2017. Acta Orthopaedica, 93, 866-873. https://doi.org/10.2340/17453674.2022.5256
Hvitfeldt Fuglsang, C. (2022). Incident Dementia Identified by Redeemed Prescriptions Recorded in The Danish National Prescription Registry. Poster session presented at 38th International Conference on Pharmacoepidemiology, Copenhagen, Denmark.
Liu, Y., Zeng, S., Huang, C., Wang, C., Zhu, J., Peng, J., Ding, F., Li, J., Qin, G. & Chen, J. (2022). Indoor Solid Fuel Use and Non-Neoplastic Digestive System Diseases: A Population-Based Cohort Study Among Chinese Middle-Aged and Older Population. International Journal of Public Health, 67, Article 1605419. https://doi.org/10.3389/ijph.2022.1605419
Nabi, H., Hendricks, O., Jensen, D. V., Loft, A. G., Pedersen, J. K., Just, S. A., Danebod, K., Munk, H. L., Kristensen, S., Manilo, N., Colic, A., Linauskas, A., Thygesen, P. H., Christensen, L. B., Kalisz, M. H., Lomborg, N., Chrysidis, S., Raun, J. L., Andersen, M. ... Glintborg, B. (2022). Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease: Clinical outcomes in real-world patients from the DANBIO registry. RMD Open, 8(2), Article 002560. https://doi.org/10.1136/rmdopen-2022-002560
Bistervels, I. M., Buchmüller, A., Wiegers, H. M. G., Ní Áinle, F., Tardy, B., Donnelly, J., Verhamme, P., Jacobsen, A. F., Hansen, A. T., Rodger, M. A., DeSancho, M. T., Shmakov, R. G., van Es, N., Prins, M. H., Chauleur, C., Middeldorp, S. & Fuglsang, J. (2022). Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial. The Lancet, 400(10365), 1777-1787. https://doi.org/10.1016/S0140-6736(22)02128-6
Vinding, N. E., Kristensen, S. L., Rørth, R., Butt, J. H., Østergaard, L., Olesen, J. B., Torp-Pedersen, C., Gislason, G. H., Køber, L., Kruuse, C., Johnsen, S. P. & Fosbøl, E. L. (2022). Ischemic Stroke Severity and Mortality in Patients With and Without Atrial Fibrillation. Journal of the American Heart Association, 11(4), Article e022638. https://doi.org/10.1161/JAHA.121.022638